bimekizumab,Adalimumab
ucb pharmaceuticals,abbvie
['bimekizumab', 'psoriatic arthritis']
from #eular2023: "breaking: bimekizumab emerges as a potential game-changer in psoriatic arthritis treatment. the latest research reveals its ability to effectively control and attenuate disease activity. learn more: #arthritis
Clinical News for Connected Physicians. Everything you need to enhance your clinical approach to improving patient care.